410 results about "Pre conditioning" patented technology

Coding techniques for a (e.g., OFDM) communication system capable of transmitting data on a number of "transmission channels" at different information bit rates based on the channels' achieved SNR. A base code is used in combination with common or variable puncturing to achieve different coding rates required by the transmission channels. The data (i.e., information bits) for a data transmission is encoded with the base code, and the coded bits for each channel (or group of channels with the similar transmission capabilities) are punctured to achieve the required coding rate. The coded bits may be interleaved (e.g., to combat fading and remove correlation between coded bits in each modulation symbol) prior to puncturing. The unpunctured coded bits are grouped into non-binary symbols and mapped to modulation symbols (e.g., using Gray mapping). The modulation symbol may be "pre-conditioned" and prior to transmission.

A dehumidifier unit for pre-conditioning air delivered to a multiplicity of separate refrigeration air conditioner units and especially ductless systems where the compressor-condenser unit is separate from the fan-coil unit, and assisted by heat pipe transfer of heat from air dehumidified through a desiccant wheel and by heat of compression from the condenser of one compressor-condenser unit, and with a heater to maintain the temperature of regeneration air through the wheel, one dehumidifier unit pre-conditioning air for a multiplicity of refrigeration air conditioners or fan-coil units.

A polyp removal tool and method of use is disclosed. The tool includes a main body, an elongated hollow conduit fixed to the body, a handle, a cable assembly, a suction assembly and an irrigation system. The handle is used to actuate a snare at the end of a cable for transecting of polypoid tissue. The suction assembly is used in pre-conditioning the tissue for cutting and in polyp retention after cutting. The irrigation system is included for tissue recovery after transection. The tool may include a screen for capture of tissue within the device.

Methods and pharmaceutical compositions for preconditioning and / or providing neuroprotection to the animal central nervous system against the effects of ischemia, trauma, metal poisoning and neurodegeneration, including the associated cognitive, behavioral and physical impairments. In one embodiment, the method is accomplished by stimulating and stabilizing hypoxia-inducible factor-1α (HIF-1α). HIF-1α is known to provide a neuroprotective benefit under ischemic conditions. Patients at risk for certain diseases or disorders that are associated with risk for cerebral ischemia may benefit, e.g., those at risk for Alzheimer's disease, Parkinson's disease, Wilson's disease or stroke or those patients having head or spinal cord injury. Patients undergoing certain medical procedures that may result in ischemia may also benefit. Initially, the possibility of ischemia or neurodegeneration is recognized. Intranasal therapeutic agents are administered to the upper third of the nasal cavity to bypass the blood-brain barrier and access the central nervous system directly to avoid unwanted and potentially lethal side effects. Therapeutic agents include those substances that interact with iron and / or copper such as iron chelators, copper chelators, and antioxidants. A particular example of such therapeutic agents is the iron chelator deferoxamine (DFO). Intranasal administration of DFO is known to stimulate and / or stabilize HIF-1α and provides an efficient and safe method for pre-conditioning the brain to protect against cerebral ischemia. Moreover, DFO is shown to decrease weight loss in subjects when administered pre and / or post stroke.

Methods and systems for detecting a biological response indicative of osteolysis or osteolytic pre-conditions in bone.